Conselho Nacional de Desenvolvimento CientÃfico e TecnolÃgico / A radiaÃÃo ionizante à considerada um fator de risco para o desenvolvimento de diversos tipos de neoplasias pelos danos causados à molÃcula de DNA, sendo de extrema importÃncia, portanto, o monitoramento de populaÃÃes humanas expostas a ela. O municÃpio de Monte Alegre no estado do Parà apresenta uma das maiores Ãreas de mineraÃÃo do urÃnio do mundo, que se estende aos municÃpios vizinhos de Prainha e Alenquer. Este trabalho teve como objetivos a avaliaÃÃo do potencial genotÃxico do urÃnio presente em rochas nas residÃncias de indivÃduos dos municÃpios de Monte Alegre, Prainha e Alenquer atravÃs do ensaio do cometa alcalino em linfÃcitos perifÃricos e a determinaÃÃo das freqÃÃncias de polimorfismos nos genes de reparo do DNA XRCC1 e XRCC3 e no gene de metabolizaÃÃo GSTM1 atravÃs de seqÃenciamento direto de DNA. Na anÃlise do cometa alcalino, nÃo houve diferenÃa estatisticamente significante entre os Ãndices de Dano (IDs) das populaÃÃes de Monte Alegre (ID = 32,01  1,57), Prainha (ID = 45,80  1,12) e Alenquer (ID = 44,30  0,62) e o do controle negativo (ID = 42,00  5,75) (p > 0,05). AtravÃs do seqÃenciamento direto de DNA, observou-se a presenÃa de polimorfismos nos genes XRCC1 e XRCC3 em regiÃes de Ãntrons e de Ãxons. No gene XRCC1, as freqÃÃncias alÃlicas variantes para o polimorfismo Arg194Trp nas populaÃÃes de Monte Alegre, Prainha e Alenquer foram 12%, 13% e 7% e, para Arg399Gln, 28%, 30% e 32%, respectivamente. No gene XRCC3, as freqÃÃncias do alelo variante do polimorfismo Thr241Met encontradas nas populaÃÃes de Monte Alegre, Prainha e Alenquer foram, respectivamente, 28%, 13% e 33%. Em relaÃÃo ao gene GSTM1, as freqÃÃncias obtidas de ausÃncia do gene apresentaram os valores de 36%, 31% e 40%, respectivamente Ãs populaÃÃes de Monte Alegre, Prainha e Alenquer. No geral, todas as freqÃÃncias alÃlicas nos Ãxons dos genes XRCC1 e XRCC3 e de ausÃncia do gene GSTM1 foram estatisticamente semelhantes entre os trÃs municÃpios e se mostraram em concordÃncia com freqÃÃncias obtidas em outros estudos com populaÃÃes brasileiras. Conclui-se que, dentre as populaÃÃes estudadas, nÃo houve aumento da incidÃncia de dano ao DNA pela exposiÃÃo ao urÃnio, o que pode se explicar pela baixa radiaÃÃo nessas localidades. AlÃm disso, as freqÃÃncias alÃlicas dos polimorfismos encontrados nos genes de reparo XRCC1 e XRCC3, assim como as de ausÃncia do gene de metabolizaÃÃo GSTM1 nÃo diferiram das encontradas em populaÃÃes de outras regiÃes do Brasil. Desse modo, nas regiÃes estudadas, possivelmente nÃo existe tendÃncia ao desenvolvimento de cÃncer induzido pela exposiÃÃo ao urÃnio. / Radiation is considered a risk factor for the development of several types of cancers caused by damage into the DNA molecule and is of extreme importance, therefore, the monitoring of human populations exposed to it. The municipality of Monte Alegre in the state of Parà in Brazil has one of the largest uranium mining areas of the world, which extends to the neighboring municipalities of Prainha and Alenquer. This work assessed the genotoxic potential of exposure to uranium in rocks found in dwellings in individuals from the municipalities of Monte Alegre, Prainha and Alenquer through the alkaline comet assay in peripheral blood lymphocytes and the determination of the frequencies of polymorphisms in DNA repair genes XRCC1 and XRCC3 and in carcinogen-metabolism gene GSTM1 through direct DNA sequencing. The analysis of the alkaline comet assay indicated that there was no statistically significant difference between the Damage Indexes (DIs) of Monte Alegre (DI = 32.01  1.57), Prainha (DI = 45.80  1.12) and Alenquer (DI = 44.30  0.62) and of the negative control (DI = 42.00  5.75) (p > 0.05). Through direct DNA sequencing, there were polymorphisms in XRCC1 and XRCC3 genes in regions of introns and exons. In XRCC1 gene, the variant allele frequencies for Arg194Trp polymorphism in Monte Alegre, Prainha and Alenquer populations were 12%, 13% and 7%, and for Arg399Gln, 28%, 30% and 32% respectively. In XRCC3 gene, the frequencies of the variant allele of Thr241Met polymorphism found in Monte Alegre, Prainha and Alenquer populations were, respectively, 28%, 13% and 33%. For GSTM1 gene, the frequencies obtained for the absence of this gene were 36%, 31% and 40%, respectively to Monte Alegre, Prainha and Alenquer populations. In general, the absence frequencies of GSTM1 gene and of allelic frequencies in XRCC1 and XRCC3 exons were statistically similar among the three municipalities and were in agreement with frequencies obtained in other studies with Brazilian populations. As a conclusion, among the populations studied, there was no increased incidence of DNA damage by exposure to uranium, which can be explained by the low radiation in these locations and that the allelic frequencies of polymorphisms found in the DNA repair genes XRCC1 and XRCC3, and the absence frequencies of GSTM1 gene did not differ from those in populations from other regions of Brazil. Thus, in the studied area, possibly there is no tendency to the development of cancer induced by exposure to uranium.

Made available in DSpace on 2014-12-17T15:32:32Z (GMT). No. of bitstreams: 1 JoabeSP_TESE.pdf: 3616540 bytes, checksum: 2904dbfc0f83145c9569635cf5feba21 (MD5) Previous issue date: 2013-09-16 / Coordena??o de Aperfei?oamento de Pessoal de N?vel Superior / Oral squamous cell carcinoma (OSCC) is an important cause of morbidity and mortality worldwide despite recent advances in treatment. There are several studies aiming to find markers that may improve the assessment of this disease prognosis. Studies about genetic polymorphisms have gained prominence due to their influence on individual susceptibility to cancer development. The aim of this study was to evaluate the association between the frequency of polymorphisms XPD Lys751Gln and XRCC3 Thr241Met and clinicopathological features of OSCC cases, including age, sex, presence or absence of metastases, and histological grading of malignancy according to Bryne (1998). Sample consisted of 54 cases of OSCC and 40 cases of inflammatory fibrous hyperplasia (IFH). OSCC cases were classified as low or high grade. DNA samples were previously extracted from paraffin blocks. Genotypes for each case were determined through PCR-RFLP (polymerase chain reaction - restriction fragment length polymorphism). Results were analyzed by Fisher s exact test and Chi-square test and the odds ratio was calculated considering p < 0.05 to indicate statistical significance. For XPD, Lys/Gln genotype was more common in IFHs (n=28; 70%) than in OSCCs (n=24; 44.4%) (OR: 0.3; p<0.05). Frequency of Gln allele was higher in high-grade lesions when compared to low grade lesions (0.48 and 0.21, respectively) (OR: 3.4; p<0.05). For XRCC3, Met allele was more common in OSCC than in IFH (0.49 and 0.35, respectively) (OR: 2.6; p<0.05). Met/Met genotype was associated with presence of metastases (OR: 8.1; p<0.05). There was no statistically significant association between the genotypes and the age or sex of patients. In the present sample, the higher frequency of XPD Gln allele in IFH reveals a possible protective role of this variant against the development of OSCC. However, its association with high-grade lesions indicates that this allele could influence the tumor progression after the neoplasia development. The presence of XRCC3 Met allele, in turn, seems to contribute to the development of OSCC and metastases / O carcinoma oral de c?lulas escamosas (COCE) ? importante causa de morbidade e mortalidade em todo o mundo a despeito dos recentes avan?os nas formas de tratamento. Diante disto, v?rias s?o as pesquisas no intuito de se encontrar marcadores que possam melhorar o progn?stico desta doen?a. Neste sentido t?m se destacado os estudos dos polimorfismos gen?ticos, os quais podem influenciar a suscetibilidade individual para o desenvolvimento do c?ncer. O objetivo deste estudo foi avaliar a associa??o entre a frequ?ncia dos polimorfismos XPD Lys751Gln e XRCC3 Thr241Met e o perfil clinicopatol?gico em casos de COCE, incluindo idade, sexo, presen?a ou n?o de met?stase e grada??o histol?gica de malignidade de Bryne (1998). A amostra foi composta por 54 casos de COCE e 40 casos de hiperplasia fibrosa inflamat?ria (HFI). Os casos de COCE foram classificados como les?es de baixo ou de alto grau de malignidade. Foram utilizadas amostras de DNA previamente extra?do de blocos de parafina. Os gen?tipos para cada caso foram determinados atrav?s da t?cnica de PCR-RFLP (rea??o em cadeia da polimerase - polimorfismos de comprimento de fragmentos de restri??o). Os resultados foram submetidos aos testes estat?sticos Exato de Fisher e Qui-quadrado de Pearson e foi calculada a raz?o de chance (odds ratio) considerando o n?vel de signific?ncia quando p<0,05. Para o XPD, o gen?tipo Lys/Gln foi mais comum nas HFIs (n=28; 70%) que nos COCEs (n=24; 44,4%) (OR: 0,3; p<0,05). A frequ?ncia do alelo Gln foi maior nas les?es de alto grau, em compara??o ?s de baixo grau (0,48 e 0,21, respectivamente) (OR: 3,4; p<0,05). Para o XRCC3, o alelo Met foi mais frequente no COCE que na HFI (0,49 e 0,35, respectivamente) (OR: 2,6; p<0,05). O gen?tipo Met/Met foi associado ? presen?a de met?stases (OR: 8,1; p<0,05). N?o houve associa??o estat?stica significativa entre os gen?tipos e a idade ou sexo dos pacientes. Na amostra analisada, a maior frequ?ncia do alelo XPD Gln na HIF revela um poss?vel papel protetor dessa variante contra o desenvolvimento do COCE. Todavia, sua associa??o com les?es de alto grau, indica que esse alelo poderia influenciar no processo de progress?o ap?s o tumor instalado. A presen?a do alelo XRCC3 Met, por sua vez, parece contribuir com o desenvolvimento do COCE e de met?stases nessas les?es

The base excision repair protein, MBD4 (also known as MED1) is known to be transcriptionally coupled to a mismatch repair protein MLH1. To date the significance of this coupling has not been elucidated and the significance of MBD4 within the mismatch repair system and apoptotic pathway is still being understood. Recently a novel alternatively spliced form of MBD4 has been identified and termed sMBD4. To date the significance of sMBD4 is unknown. MBD4 and sMBD4 share a common glycosylase domain and this is the domain through which MBD4 is reported to interact with MLH1. It was the aim of this study to determine if sMBD4 was also a binding partner of MLH1 to help elucidate a potential role of sMBD4 and to further characterise the binding domain between MLH1 and MBD4. Recombinant proteins were utilised in binding assays however, a specific protein – protein interaction could not be determined. Regular aspirin intake is associated with a reduction in the incidence of colorectal cancer. Aspirin has been shown to be cytotoxic to colorectal cancer cells in vitro. The molecular basis for this cytotoxicity is controversial, with a number of competing hypotheses in circulation. One suggestion is that the protective effect is related to the induction of DNA mismatch repair (MMR) proteins in DNA MMR proficient cells. As MBD4 has previously been suggested to be coupled to MLH1 expression by a post‐translational mechanism the cytotoxicy of aspirin in relation to MBD4 expression was examined. This study reports that aspirin does not up‐regulate MBD4 gene transcription in vitro in the DNA mismatch repair proficient/p53 mutant colorectal cancer cell line SW480. However, MBD4 gene transcription was up‐regulated upon treatment with the aspirin precursor, salicylic acid. The suggested involvement of the DNA repair proteins in the mechanism of action of aspirin promoted the investigation into the expression of DNA damage signalling pathways genes upon aspirin exposure. This study utilised a commercially available PCR array to analyse the expression of 84 DNA damage signalling genes in the SW480 colorectal cancer cell line upon aspirin treatment. It is reported that treatment of the SW480 cell line with aspirin caused changes in mRNA expression of several key genes involved in DNA damage signalling including a significant down‐regulation in expression of the genes encoding ATR, BRCA1 and MAPK12 and increases in the expression of XRCC3 and GADD45α genes. Regulation of these genes could potentially have profound effects on colorectal cancer cells and may play a role in the observed chemo‐protective effect of aspirin in vivo.Further to this, protein expression was analysed to determine if correlation could be established with the changes in mRNA expression observed. Although a correlation was not seen between transcript and protein levels of ATR, BRCA1 and GADD45α, an increase in XRCC3 protein expression upon aspirin treatment in SW480 cells was observed by immunoblotting, immunofluorescence and immunohistochemical analysis. This study indicates that alterations in gene expression seen in microarray studies need to be verified at the protein level. Furthermore, this study reports the novel discovery of XRCC3 gene and protein expression being susceptible to exposure to the non‐steroidal anti‐inflammatory drug, aspirin.

In this study, the role of two DNA repair genes, X-ray repair cross complementing group 3 (XRCC3) Thr241Met and Rad51 G135C polymorphisms were investigated in the risk of development of childhood ALL in Turkish population among 193 healthy controls and 184 ALL patients, by using PCR-RFLP technique. For XRCC3 Thr241Met polymorphism, the frequencies of both heterozygous and homozygous mutant genotypes were found to be higher in the controls compared to ALL patients (OR: 0.59, p = 0.02 / OR: 0.48, p = 0.02, respectively). In addition, either heterozygous (Thr/Met) or homozygous mutant (Met/Met) genotypes were significantly more common in the controls than the ALL patients (OR: 0.55, p =0.005). In case of Rad51 G135C polymorphism, no significant associations have been found with the risk of childhood ALL. Combination of XRCC3 heterozygote and Rad51 heterozygote genotypes increased the protective effect for risk of childhood ALL. (OR=0.35 / p =0.02). Combination of homozygote mutant genotype of XRCC3 with homozygote wild type genotype of Rad51 gave a highly statistically proved protective effect for the development of disease (OR= 0.36 / p= 0.004). To our knowledge, this is the first study showing the protective role of XRCC3 Thr241Met polymorphism either alone or in combination with Rad51 G135C variant on the risk of development of childhood ALL. In addition, interactions of these polymorphisms with non-genetic risk factors were investigated. Only in terms of paternal exposure, the heterozygote (Thr/Met) genotype for XRCC3 gene in children whose father exposed to cigarette smoke demonstrated a significant risk of 3.0 fold (p=0.05). Moreover, the frequency of Rad51 135C allele was determined for the first time in Turkish population. The frequency of the mutant allele was found to be very similar to that observed in other Caucasian populations.

Protection of the genome from carcinogenic consequences of DNA double-strand breaks (DSBs) is accomplished through the pathways of non-homologous end-joining (NHEJ) or homologous recombinational repair. Five human proteins with homology to Rad51 known as the Rad51 paralogs, Rad51B, Rad51C, Rad51D, XRCC2, and XRCC3, whose loss of function in cell lines leads to high chromosomal instability. Previous studies have shown Rad51C participate in two paralog protein complexes, one containing Rad51B, Rad51C, Rad51D and XRCC2 (BCDX2) and the other containing only Rad51C and XRCC3 (CX3). However, the only structural data available is the crystal structure of RecA, the bacterial homolog, the determination of the N-terminus of human Rad51 by NMR, and the crystal structure of Pyroccocus furious Rad51. Currently the Alvinlla pompejana Rad51C has been cloned, expressed and is currently being crystallized in the Tainer laboratory (UC Berkeley) since the human Rad51C protein has proven too difficult to be utilized. To test functional association of Hs Rad51B and Hs XRCC3 to Ap Rad51C. The human proteins were heterologously expressed in Pichia pastoris and the other expressed in E. coli. The proteins were extracted and interaction was tested through co-immunoprecipitation. Initial results depict weak binding or an unstable interaction between Hs Rad51B and Ap Rad51C. Hs XRCC3 and Ap Rad51C interaction remains unclear and requires further testing. Additionally, we have utilized a cellular model of HNSCC to identify whether the down-regulation of Rad51 after application of VD 3 is concomitant with the down-regulation of NBS1. NBS1 is a DNA repair protein involved in both pathways of DNA double-strand break repair, non-homologous end-joining and homologous recombinational repair. It has recently been demonstrated that NBS1 binds to Rad51 aiding in its localization to sites of DNA damage. VD 3 is a potential chemopreventive agent in the treatment of head and neck cancer. For the in vitro model Rad51 and NBS1 protein were both extracted from SCC25 and MCF-7 cancer cell lines were treated with 100 nM of VD 3 . For the in vivo model hamsters cheek pouch tissue sections with VD 3 treated and DMBA over the course of 14 weeks were used. Rad51 and NBS1 staining is restricted to the nuclei of the basal cell layer of the epithelium in VD 3 treated animals as compared to untreated controls where staining is evident throughout the dysplastic epithelium and is not restricted to nuclei. Unlike the western blot data of Rad51 that shows similar downregulation as the immunocytochemistry, the western blot analysis of NBS1 is unclear. However, the immunocytochemistry suggests that NBS1 is also downregulated by VD 3 in vivo, and therefore, it may be implied that both the HRR and NHEJ pathways are involved in the cellular effects of VD 3 in HNSCC.

Acquisition of invasiveness through extracellular matrix is a crucial characteristic of transition to malignancy in the breast. It was previously shown that Polo-like kinase 1 (PLK-1), a mitotic kinase and genome stability regulator, is involved in acquisition of invasiveness in a breast cell model (HMT-3522 cell line) of pre-invasive to invasive transition. This and other data led to the suggestion that a new class of genes called GISEM for Genome Instability and Extracellular Matrix Invasiveness may exist. Previous lab data show that XRCC3 is found downregulated in progression from preinvasive to invasive phenotype. This led to the hypothesis that XRCC3 may be a negative regulator of invasion. To support this hypothesis, overexpression of XRCC3 in the invasive T4-2 cells downregulated invasion, but also growth. In order to verify the role of XRCC3 in invasiveness, and determine whether it is independent from any effects on growth, we tested the effect of downregulating XRCC3 on the invasiveness of T4-2 cells. Short-term downregulation of XRCC3 using siRNAs produced a significant increase in invasiveness, suggesting a role for XRCC3 as a negative regulator of invasion. During the invasion assay time course, XRCC3 downregulation had no effect on growth or apoptosis supporting the idea that this is a direct effect on invasion and not an artifact of the assay. XRCC3 is one amongst the five members of the RAD51 paralog family, consisting of accessory proteins or RAD51 cofactors (namely RAD51B, RAD51C, RAD51D, XRCC2 and XRCC3) which interact with each other to form complexes (BCDX2, BC, DX2 and CX3) that collaboratively assist RAD51 in homologous recombinational repair (HRR) of DNA double-strand breaks. To see if these interactions are important in terms of invasion, as they have been demonstrated for DNA repair, we studied the effect of XRCC3 downregulation on the levels of RAD51 paralogs. We found lowered levels of RAD51C, but not RAD51B or RAD51D, when XRCC3 was downregulated. Since XRCC3 forms the CX3 complex with RAD51C, we downregulated RAD51C using siRNAs in T4-2 cells and found this to significantly increase invasiveness. Consistent with previous findings by other groups, downregulating RAD51C also lead to decreased levels of XRCC3 in invasive T4-2 cells. These results suggest that the XRCC3-RAD51C interaction is important for invasion as well as the previously studied DNA repair function. In delineating the mechanism by which XRCC3 acts as a negative regulator of invasion, we further questioned if XRCC3 alters secreted factors that are important for the invasiveness of T4-2 cells and tested the effects of conditioned medium (CM) from XRCC3 altered T4-2 cells on parental T4-2 cells’ ability to invade. Results show a significant increase in invading T4-2 cells when suspended in CM from XRCC3 siRNA transfected T4-2 cells, suggesting a direct effect of XRCC3 siRNAs on the ability of T4-2 CM to induce invasiveness in T4-2 cells. Furthermore, we investigated the effects of XRCC3 inhibition on cell surface integrins and focal adhesion kinase (FAK). Indirect immunofluorescence results show increased formation of focal adhesions containing two phosphorylated FAK residues- autophosphorylated FAK-Y397 and FAK-Y861 (previously implicated in increased migration and invasion of tumor cells) in XRCC3 siRNA transfected T4-2 cells. Overall, these results support a new role of XRCC3 in invasion, in addition to its previously reported role in DNA repair. These findings imply that loss of XRCC3 function in cancer progression would upregulate invasion as well as downregulate DNA repair and genome stability. Therefore, stabilization of XRCC3 function could provide a promising therapeutic against breast cancer progression. The dual role of XRCC3 in invasion and DNA repair also renders it an attractive candidate risk biomarker of breast pre-cancer to invasive cancer progression.

Submitted by Automa??o e Estat?stica (sst@bczm.ufrn.br) on 2016-08-25T20:42:57Z No. of bitstreams: 1 EdilmarDeMouraSantos_TESE.pdf: 2404882 bytes, checksum: 5eff55db010b690ecc915ee6c24050f0 (MD5) / Approved for entry into archive by Arlan Eloi Leite Silva (eloihistoriador@yahoo.com.br) on 2016-08-26T19:45:12Z (GMT) No. of bitstreams: 1 EdilmarDeMouraSantos_TESE.pdf: 2404882 bytes, checksum: 5eff55db010b690ecc915ee6c24050f0 (MD5) / Made available in DSpace on 2016-08-26T19:45:12Z (GMT). No. of bitstreams: 1 EdilmarDeMouraSantos_TESE.pdf: 2404882 bytes, checksum: 5eff55db010b690ecc915ee6c24050f0 (MD5) Previous issue date: 2016-02-24 / Conselho Nacional de Desenvolvimento Cient?fico e Tecnol?gico (CNPq) / Falhas nos genes respons?veis por reparos no DNA podem influenciar no surgimento de c?ncer ou afetar a resposta aos tratamentos. Estudos t?m demonstrado que a varia??o na capacidade de reparo do DNA pode ser resultado de polimorfismos funcionais nestes genes, e alguns destes experimentos sugerem que a presen?a de polimorfismos de nucleot?deos simples (SNPs), em genes de reparo, est? relacionada ao desenvolvimento e resposta ao tratamento de v?rios c?nceres, incluindo o Carcinoma Epidermoide Oral (CEO) e o Carcinoma Epidermoide de Orofaringe (CEOR). Nesta pesquisa avaliou-se a frequ?ncia de tr?s SNPs em dois genes de reparo do DNA RAD51 172G>T (c.-61 G>T, rs1801321), RAD51 135G>C (c.-98 G>C, rs1801320) e XRCC3 T241M (c. 722 C>T, rs861539) em indiv?duos saud?veis (n=130) e indiv?duos com CEO e CEOR (n=126) e investigou-se poss?veis rela??es de tais achados com os desfechos cl?nicos: resposta tumoral ao tratamento com radioterapia e quimioterapia, recidiva, e sobrevida global. Constatou-se frequ?ncia al?lica e genot?pica em equil?brio. A presen?a dos SNPs analisados n?o revelou ser um fator de risco para o desenvolvimento de CEO ou CEOR; contudo, quando associado ao h?bito de fumar ou beber, aumentou o risco de desenvolver o c?ncer de tr?s a cento e cinquenta vezes (p<000,1). A resposta tumoral ao tratamento de radioterapia e quimioterapia foi semelhante nos pacientes com ou sem SNPs. Nenhum polimorfismo demonstrou signific?ncia estat?stica em rela??o ? sobrevida livre de recidiva ou sobrevida global. Os gen?tipos AA e AC do SNP rs861539 no gene XRCC3, os gen?tipos CC e CG do SNP rs1801320 e GG e GT do SNP 1801321 no gene RAD51, aumentam o risco do desenvolvimento de carcinoma epidermoide oral e de orofaringe, quando associados ao h?bito de beber ou fumar. Os polimorfismos estudados nos genes XRCC3 e RAD51 n?o est?o associados ? resposta ? radioterapia, sobrevida livre de recidiva ou sobrevida global. / Faults in the genes responsible for repairs to the DNA can influence the onset of cancer or affect the response to treatment. This research evaluated the frequency of three single nucleotide polymorphisms (SNPs) in two repair genes DNA RAD51 172g> T (rs1801321), RAD51 135G> C (rs1801320) and XRCC3 T241M (rs861539) in individuals without cancer (n = 130) and patients with oral squamous cell carcinoma (OSC) and carcinoma oropharyngeal squamous (ORSC) (n = 126) and investigated possible relationships of these findings with clinical and pathological data and clinical outcomes: tumor response to radiotherapy and chemotherapy, disease-free survival, and overall survival. It was found that the allele and genotype frequencies were in equilibrium Hard-Weinberg equilibrium. The presence of at least one polymorphic allele in XRCC3 (rs861539) gene is associated with histological grade (WHO) higher (p = 0.007). We observed a higher recurrence rate trend (p = 0.08) and more advanced stage (p = 0.08) in the group that had at least one polymorphic allele of RAD51 gene (rs1801321). The presence of the analyzed SNPs not proved to be a risk factor for the development of CEO or CEOR; however, when combined with smoking or drinking, increased the risk of developing cancer from three to one hundred and fifty times. The tumor response to radiotherapy and chemotherapy was similar in patients with and without SNPs. No polymorphism showed statistical significance in relation to recurrence-free survival or overall survival. We conclude that the presence of at least one polymorphic allele of the SNPs rs861539 in XRCC3 gene, rs1801320 and rs1801321 in the RAD51 gene increase the risk of development of OSC and ORSC, when associated with the habit of drinking or smoking. Polymorphisms studied in XRCC3 and RAD51 genes are not associated with response to radiation therapy, relapse-free survival or overall survival.

Introdução: As radiações ionizantes produzem efeitos na molécula do DNA e o biomonitoramento in vivo pode ser utilizado para melhor avaliar o nível de exposição interna à radiação. Os agentes genotóxicos em populações expostas geram diferentes danos ao DNA e por existir uma variabilidade genética isso acarreta sensibilidades diferentes a estes agentes. Essa variação pode ser explicada pela existência de polimorfismos genéticos envolvidos no processo de reparo, entre eles o XRCC1 e XRCC3, responsáveis por manter a integridade do genoma das células frente a danos causados pelos agentes mutagênicos, como a radiação ionizante. Objetivo: Avaliar os efeitos mutagênicos da exposição à radiação x e gama em pacientes que realizam cintilografia miocárdica e angioplastia miocárdica e relacionar os possíveis resultados positivos com os polimorfismos dos genes de reparo, XRCC1 e XRCC3. Materiais e Métodos: Foram selecionados 57 pacientes expostos à radiação gama, e 57 expostos à radiação X. A análise da instabilidade genômica foi realizada através dos testes do micronúcleo e cometa, e a genotipagem através de sonda de TaqMan, para os polimorfismos do gene de reparo XRCC1 e XRCC3. Resultados e Conclusões: Em nosso estudo, os dados encontrados demonstram que ocorre dano ao DNA, após a exposição à radiação gama (ƿ=0,026). No entanto, não observamos ocorrer influência dos diferentes genótipos em ambos polimorfismos estudados, Arg399Gln e Thr241 Met, embora a presença do genótipo mutado Met/Met, parece ter indicado menor radiossensibilidade. Apesar desta diferença não ter alcançado os níveis de significância esperados, este resultado está de acordo com dados da literatura que indicam que este genótipo poderia estar associado à capacidade de reparação do DNA. Neste mesmo grupo, não encontramos diferenças estatisticamente significativas para aberrações cromossômicas (MN e NBUDs) após a exposição, para ambos polimorfismos, exceto para o genótipo normal Arg/Arg (ƿ=0,012), que parece ter indicado maior radiossensibilidade à exposição, estando de acordo com trabalhos da literatura, os quais demostram que, este genótipo pode ser associado com a diminuição da capacidade de reparo do DNA, apresentando níveis mais altos de quebras induzidas. As evidências de radiossensibilidade celular também podem ser explicadas pela alteração da proteína resultante do polimorfismo que não corrige os danos ao DNA, podendo aumentar o acúmulo de lesões no material genético, possivelmente pelo efeito da dose, tempo e tipo de exposição da radiação. Já no grupo de pacientes expostos à radiação X, observamos que não ocorre aumento nos níveis de danos ao DNA após a exposição (ƿ=0,004) e que não existe efeito de ambos polimorfismos estudados, exceto para o genótipo mutado Met/Met que parece determinar maior radiossensibilidade (ƿ=0,041). Para este grupo, observamos que ocorre aumento nas frequências de MN (ƿ<0,001) e NBUDs (ƿ<0,001), mas que os diferentes genótipos não influenciaram diferenças para estes achados. Para os dados de aberrações cromossômicas, encontrados neste grupo, a superexposição radiológica pode ser a interpretação dos achados, já que os detectores planos dos equipamentos utilizados aumentam em torno de 65% a exposição aos pacientes, quando comparados aos antigos intensificadores de imagens. / Introduction: Ionizing radiations produce effects on the DNA molecule and biomonitoring in vivo may be used to better assess the level of internal radiation exposure. Genotoxic agents in exposed populations generate different DNA damage, and there is a genetic variation in sensitivity to these agents. This variation can be explained by the existence of genetic polymorphisms involved in the repair process, including XRCC1 and XRCC3, responsible for maintaining genome integrity of the cell by the damage caused by mutagenic agents, such as ionizing radiation. Objective: Assess the mutagenic effects of exposure to x and gamma radiation in patients undergoing myocardial scintigraphy and coronary angioplasty and relate the possible positive result with polymorphisms of repair genes, XRCC1 and XRCC3. Materials and Methods: 57 patients exposed to gamma radiation, and 57 exposed to x radiation were selected. Analysis of genomic instability was performed by the micronucleus comet assay, and genotyping using TaqMan probe for polymorphisms XRCC1 and XRCC3 repairing genes. Results and Conclusions: In our study the data found demonstrate that DNA damage occurs after exposure to gamma radiation (ƿ=0.026). However, we did not observed influence of the different genotypes for both polymorphisms, Arg399Gln and Thr241Met, although the presence of the mutated genotype Met/Met seems to be less radiosensitive. Despite this difference did not reach statistical significance, this result is in agreement with data reported in the literature indicating that this genotype might be associated with the ability of DNA repair. In this group, we found no statistically significant differences in chromosomal aberrations (MN and NBUDs) after exposure for both polymorphisms, except for the normal genotype Arg/Arg (ƿ= 0.012), that seems to have shown greater radiosensitivity exposure, which is consistent with literature studies, which demonstrate that this genotype may be associated with decreased DNA repair capacity, showing higher levels of induced breaks. Evidence of cellular radiosensitivity may also be explained by the alteration of the protein resulting from polymorphism that does not correct the DNA damage and may increase the accumulation of lesions in the genetic material, possibly the effect of the dose, time and type of radiation exposure. In the group of patients exposed to x-radiation, we observe that no increase in the levels of DNA damage after exposure (ƿ=0.004) and that there is no effect of both polymorphisms studied, except for the mutated genotype Met / Met that seems to determine higher radiosensitivity (ƿ=0.041). For this group, we observed an increase in the frequency of MN (ƿ<0.001) and NBUDs (ƿ<0.001), but the different genotypes did not influence differences for these findings. For the data of chromosomal aberrations found in this group, radiological overexposure may be the interpretation of the findings, since the flat detectors of the equipment used increase around 65% exposure to patients, when compared to the old image intensifiers.

Introdução: As radiações ionizantes produzem efeitos na molécula do DNA e o biomonitoramento in vivo pode ser utilizado para melhor avaliar o nível de exposição interna à radiação. Os agentes genotóxicos em populações expostas geram diferentes danos ao DNA e por existir uma variabilidade genética isso acarreta sensibilidades diferentes a estes agentes. Essa variação pode ser explicada pela existência de polimorfismos genéticos envolvidos no processo de reparo, entre eles o XRCC1 e XRCC3, responsáveis por manter a integridade do genoma das células frente a danos causados pelos agentes mutagênicos, como a radiação ionizante. Objetivo: Avaliar os efeitos mutagênicos da exposição à radiação x e gama em pacientes que realizam cintilografia miocárdica e angioplastia miocárdica e relacionar os possíveis resultados positivos com os polimorfismos dos genes de reparo, XRCC1 e XRCC3. Materiais e Métodos: Foram selecionados 57 pacientes expostos à radiação gama, e 57 expostos à radiação X. A análise da instabilidade genômica foi realizada através dos testes do micronúcleo e cometa, e a genotipagem através de sonda de TaqMan, para os polimorfismos do gene de reparo XRCC1 e XRCC3. Resultados e Conclusões: Em nosso estudo, os dados encontrados demonstram que ocorre dano ao DNA, após a exposição à radiação gama (ƿ=0,026). No entanto, não observamos ocorrer influência dos diferentes genótipos em ambos polimorfismos estudados, Arg399Gln e Thr241 Met, embora a presença do genótipo mutado Met/Met, parece ter indicado menor radiossensibilidade. Apesar desta diferença não ter alcançado os níveis de significância esperados, este resultado está de acordo com dados da literatura que indicam que este genótipo poderia estar associado à capacidade de reparação do DNA. Neste mesmo grupo, não encontramos diferenças estatisticamente significativas para aberrações cromossômicas (MN e NBUDs) após a exposição, para ambos polimorfismos, exceto para o genótipo normal Arg/Arg (ƿ=0,012), que parece ter indicado maior radiossensibilidade à exposição, estando de acordo com trabalhos da literatura, os quais demostram que, este genótipo pode ser associado com a diminuição da capacidade de reparo do DNA, apresentando níveis mais altos de quebras induzidas. As evidências de radiossensibilidade celular também podem ser explicadas pela alteração da proteína resultante do polimorfismo que não corrige os danos ao DNA, podendo aumentar o acúmulo de lesões no material genético, possivelmente pelo efeito da dose, tempo e tipo de exposição da radiação. Já no grupo de pacientes expostos à radiação X, observamos que não ocorre aumento nos níveis de danos ao DNA após a exposição (ƿ=0,004) e que não existe efeito de ambos polimorfismos estudados, exceto para o genótipo mutado Met/Met que parece determinar maior radiossensibilidade (ƿ=0,041). Para este grupo, observamos que ocorre aumento nas frequências de MN (ƿ<0,001) e NBUDs (ƿ<0,001), mas que os diferentes genótipos não influenciaram diferenças para estes achados. Para os dados de aberrações cromossômicas, encontrados neste grupo, a superexposição radiológica pode ser a interpretação dos achados, já que os detectores planos dos equipamentos utilizados aumentam em torno de 65% a exposição aos pacientes, quando comparados aos antigos intensificadores de imagens. / Introduction: Ionizing radiations produce effects on the DNA molecule and biomonitoring in vivo may be used to better assess the level of internal radiation exposure. Genotoxic agents in exposed populations generate different DNA damage, and there is a genetic variation in sensitivity to these agents. This variation can be explained by the existence of genetic polymorphisms involved in the repair process, including XRCC1 and XRCC3, responsible for maintaining genome integrity of the cell by the damage caused by mutagenic agents, such as ionizing radiation. Objective: Assess the mutagenic effects of exposure to x and gamma radiation in patients undergoing myocardial scintigraphy and coronary angioplasty and relate the possible positive result with polymorphisms of repair genes, XRCC1 and XRCC3. Materials and Methods: 57 patients exposed to gamma radiation, and 57 exposed to x radiation were selected. Analysis of genomic instability was performed by the micronucleus comet assay, and genotyping using TaqMan probe for polymorphisms XRCC1 and XRCC3 repairing genes. Results and Conclusions: In our study the data found demonstrate that DNA damage occurs after exposure to gamma radiation (ƿ=0.026). However, we did not observed influence of the different genotypes for both polymorphisms, Arg399Gln and Thr241Met, although the presence of the mutated genotype Met/Met seems to be less radiosensitive. Despite this difference did not reach statistical significance, this result is in agreement with data reported in the literature indicating that this genotype might be associated with the ability of DNA repair. In this group, we found no statistically significant differences in chromosomal aberrations (MN and NBUDs) after exposure for both polymorphisms, except for the normal genotype Arg/Arg (ƿ= 0.012), that seems to have shown greater radiosensitivity exposure, which is consistent with literature studies, which demonstrate that this genotype may be associated with decreased DNA repair capacity, showing higher levels of induced breaks. Evidence of cellular radiosensitivity may also be explained by the alteration of the protein resulting from polymorphism that does not correct the DNA damage and may increase the accumulation of lesions in the genetic material, possibly the effect of the dose, time and type of radiation exposure. In the group of patients exposed to x-radiation, we observe that no increase in the levels of DNA damage after exposure (ƿ=0.004) and that there is no effect of both polymorphisms studied, except for the mutated genotype Met / Met that seems to determine higher radiosensitivity (ƿ=0.041). For this group, we observed an increase in the frequency of MN (ƿ<0.001) and NBUDs (ƿ<0.001), but the different genotypes did not influence differences for these findings. For the data of chromosomal aberrations found in this group, radiological overexposure may be the interpretation of the findings, since the flat detectors of the equipment used increase around 65% exposure to patients, when compared to the old image intensifiers.

Introdução: As radiações ionizantes produzem efeitos na molécula do DNA e o biomonitoramento in vivo pode ser utilizado para melhor avaliar o nível de exposição interna à radiação. Os agentes genotóxicos em populações expostas geram diferentes danos ao DNA e por existir uma variabilidade genética isso acarreta sensibilidades diferentes a estes agentes. Essa variação pode ser explicada pela existência de polimorfismos genéticos envolvidos no processo de reparo, entre eles o XRCC1 e XRCC3, responsáveis por manter a integridade do genoma das células frente a danos causados pelos agentes mutagênicos, como a radiação ionizante. Objetivo: Avaliar os efeitos mutagênicos da exposição à radiação x e gama em pacientes que realizam cintilografia miocárdica e angioplastia miocárdica e relacionar os possíveis resultados positivos com os polimorfismos dos genes de reparo, XRCC1 e XRCC3. Materiais e Métodos: Foram selecionados 57 pacientes expostos à radiação gama, e 57 expostos à radiação X. A análise da instabilidade genômica foi realizada através dos testes do micronúcleo e cometa, e a genotipagem através de sonda de TaqMan, para os polimorfismos do gene de reparo XRCC1 e XRCC3. Resultados e Conclusões: Em nosso estudo, os dados encontrados demonstram que ocorre dano ao DNA, após a exposição à radiação gama (ƿ=0,026). No entanto, não observamos ocorrer influência dos diferentes genótipos em ambos polimorfismos estudados, Arg399Gln e Thr241 Met, embora a presença do genótipo mutado Met/Met, parece ter indicado menor radiossensibilidade. Apesar desta diferença não ter alcançado os níveis de significância esperados, este resultado está de acordo com dados da literatura que indicam que este genótipo poderia estar associado à capacidade de reparação do DNA. Neste mesmo grupo, não encontramos diferenças estatisticamente significativas para aberrações cromossômicas (MN e NBUDs) após a exposição, para ambos polimorfismos, exceto para o genótipo normal Arg/Arg (ƿ=0,012), que parece ter indicado maior radiossensibilidade à exposição, estando de acordo com trabalhos da literatura, os quais demostram que, este genótipo pode ser associado com a diminuição da capacidade de reparo do DNA, apresentando níveis mais altos de quebras induzidas. As evidências de radiossensibilidade celular também podem ser explicadas pela alteração da proteína resultante do polimorfismo que não corrige os danos ao DNA, podendo aumentar o acúmulo de lesões no material genético, possivelmente pelo efeito da dose, tempo e tipo de exposição da radiação. Já no grupo de pacientes expostos à radiação X, observamos que não ocorre aumento nos níveis de danos ao DNA após a exposição (ƿ=0,004) e que não existe efeito de ambos polimorfismos estudados, exceto para o genótipo mutado Met/Met que parece determinar maior radiossensibilidade (ƿ=0,041). Para este grupo, observamos que ocorre aumento nas frequências de MN (ƿ<0,001) e NBUDs (ƿ<0,001), mas que os diferentes genótipos não influenciaram diferenças para estes achados. Para os dados de aberrações cromossômicas, encontrados neste grupo, a superexposição radiológica pode ser a interpretação dos achados, já que os detectores planos dos equipamentos utilizados aumentam em torno de 65% a exposição aos pacientes, quando comparados aos antigos intensificadores de imagens. / Introduction: Ionizing radiations produce effects on the DNA molecule and biomonitoring in vivo may be used to better assess the level of internal radiation exposure. Genotoxic agents in exposed populations generate different DNA damage, and there is a genetic variation in sensitivity to these agents. This variation can be explained by the existence of genetic polymorphisms involved in the repair process, including XRCC1 and XRCC3, responsible for maintaining genome integrity of the cell by the damage caused by mutagenic agents, such as ionizing radiation. Objective: Assess the mutagenic effects of exposure to x and gamma radiation in patients undergoing myocardial scintigraphy and coronary angioplasty and relate the possible positive result with polymorphisms of repair genes, XRCC1 and XRCC3. Materials and Methods: 57 patients exposed to gamma radiation, and 57 exposed to x radiation were selected. Analysis of genomic instability was performed by the micronucleus comet assay, and genotyping using TaqMan probe for polymorphisms XRCC1 and XRCC3 repairing genes. Results and Conclusions: In our study the data found demonstrate that DNA damage occurs after exposure to gamma radiation (ƿ=0.026). However, we did not observed influence of the different genotypes for both polymorphisms, Arg399Gln and Thr241Met, although the presence of the mutated genotype Met/Met seems to be less radiosensitive. Despite this difference did not reach statistical significance, this result is in agreement with data reported in the literature indicating that this genotype might be associated with the ability of DNA repair. In this group, we found no statistically significant differences in chromosomal aberrations (MN and NBUDs) after exposure for both polymorphisms, except for the normal genotype Arg/Arg (ƿ= 0.012), that seems to have shown greater radiosensitivity exposure, which is consistent with literature studies, which demonstrate that this genotype may be associated with decreased DNA repair capacity, showing higher levels of induced breaks. Evidence of cellular radiosensitivity may also be explained by the alteration of the protein resulting from polymorphism that does not correct the DNA damage and may increase the accumulation of lesions in the genetic material, possibly the effect of the dose, time and type of radiation exposure. In the group of patients exposed to x-radiation, we observe that no increase in the levels of DNA damage after exposure (ƿ=0.004) and that there is no effect of both polymorphisms studied, except for the mutated genotype Met / Met that seems to determine higher radiosensitivity (ƿ=0.041). For this group, we observed an increase in the frequency of MN (ƿ<0.001) and NBUDs (ƿ<0.001), but the different genotypes did not influence differences for these findings. For the data of chromosomal aberrations found in this group, radiological overexposure may be the interpretation of the findings, since the flat detectors of the equipment used increase around 65% exposure to patients, when compared to the old image intensifiers.